C07C 233/19
Having the carbon atom of the carboxamide group bound to an acyclic
Official title: having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
C07C233/19 (Having the carbon atom of the carboxamide group bound to an acyclic) appears on 20 US grants and 13 published applications in this corpus.
Search patents in C07C- Granted patents
- 20
- Published applications
- 13
- Assignees
- 17
- Inventors
- 73
- Latest grant
- 20 Aug 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 2 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Trialkyne linking agents and methods of use20 Aug 2024US 12,065,458 B2Arrowhead Pharmaceuticals, Inc.
- Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy4 Aug 2015US 9,096,619 B2AbbVie Deutschland GmbH & Co. KG
- Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy30 Jun 2015US 9,067,871 B2AbbVie Deutschland GmbH & Co. KG
- Synthesis of tripodal catechol derivatives having an adamantyl basic framework for functionalizing surfaces22 Jul 2014US 8,785,641 B2Justus-Liebig-Universitat Giessen
- Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy22 Oct 2013US 8,563,617 B2Abbott Laboratories
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors17 Jul 2025US 2025/0230125 A1
- Trialkyne Linking Agents and Methods of Use20 Mar 2025US 2025/0092072 A1Arrowhead Pharmaceuticals, Inc.
- Trialkyne Linking Agents and Methods of Use22 Dec 2022US 2022/0402947 A1Arrowhead Pharmaceuticals, Inc.
- Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy30 Jan 2014US 2014/0031331 A1AbbVie Deutschland GmbH & Co. KG
Most cited
By later US patents
- Aryl(alkyl)propylamides50US 5,731,352 AAdir et Compagnie · 1998
- Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids30US 5,424,414 AAbbott Laboratories · 1995
- 1-aryl-2-hydroxyethyl amides as potassium channel openers19US 7,045,551 B2Bristol-Myers Squibb Company · 2006
- 2-methylprop anamides and their use as pharmaceuticals13US 7,687,665 B2Incyte Corporation · 2010
- Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy12US 8,563,617 B2Abbott Laboratories · 2013